Latest Breaking News On - Lisocabtagene maraleucel liso - Page 1 : comparemela.com

Alexey Danilov, MD, PhD, reviews data from the phase 2 TRANSCEND FL trial investigating lisocabtagene maraleucel and discusses the clinical implications of the results.

Lymphomes folliculairesAlexey danilovLisocabtagene maraleucel lisoLisocabtagene maraleucelFl international prognostic indexPatients withPartnership withEtude des lymphomes folliculairesAnn arborFollicular lymphomaTranscend flLiso celRelapsed refractory follicular lymphomaCart cell therapyOverall response rateAdverse events